Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ejabCfbwocfagWrdyyXI

January 31, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
 
  • Panel doubts agents' role in improving Alzheimer's diagnosis
    The Medicare Evidence Development & Coverage Advisory Committee showed a lack of confidence in the use of imaging agents to detect brain plaques linked to Alzheimer's disease risk. Only one of the 12 voting members expressed intermediate to high confidence that the agents will help improve outcomes in patients showing early signs of memory problems. This lack of confidence may lead to CMS reimbursement problems for Eli Lilly & Co.'s FDA-approved imaging agent Amyvid. Lilly said it is confident of the usefulness of its product in evaluating patients suspected of having Alzheimer's. Reuters (1/30) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Your initiatives. Our technology. Together, we can reduce radiation exposure.
Utilizing a fully shielded, mobile design, the MEDRAD™ Intego™ enables sites to infuse doses-on-demand from a multi-dose vial, providing clinicians with added protection and more accurate, repeatable, patient-specific dosing. Click here to learn more.
  Clinical News & Research 
  • PET/CT measures ENDO-HDR response, may let patients skip chemo
    PET/CT imaging can determine pathological response in postsurgery patients with stage II and III rectal cancer who underwent short high-dose-rate endorectal brachytherapy prior to surgery, according to results presented at a gastrointestinal cancers meeting. ENDO-HDR may allow patients to avoid chemotherapy before surgery, researchers said. They also hope the method will allow for nonoperative management of many patients. AuntMinnie.com (free registration) (1/30) LinkedInFacebookTwitterEmail this Story
 
  • Study: Most older patients have stress test, angio after PCI
    Noninvasive stress testing and invasive coronary angiography were performed on almost 60% of older patients who underwent percutaneous coronary intervention, according to a study published in Circulation: Cardiovascular Imaging. The results indicate there may be ways to improve the identification of patients who may benefit from these tests after PCI, researchers said. "During the time period studied, we did see a modest but significant decline in testing rates after PCI driven by declines in [stress testing] rates, especially nuclear [stress tests]," researchers said. Healio/Cardiology Today's Intervention (1/30) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Selling your business? Here are 7 things you should do now.
If you're considering selling your business, you should be doing everything you can to get the best possible price. In just 7 simple steps you can improve your chances of attracting buyers and getting big bucks for your business. Read the article and learn the 7 steps.

  Industry Report 
  • Navidea sells shares to raise funds for operations
    Navidea Biopharmaceuticals said it has sold 1.5 million shares to J.P. Morgan Chase & Co.'s asset management unit and an additional investor to raise money to support its operations while it waits for an FDA decision on its radiopharmaceutical agent Lymphoseek. Navidea expects a decision in April and is also pursuing European approval for the agent. The Wall Street Journal/Dow Jones Newswires (1/30) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  Health Policy 
  Grants and Funding 
  • FDA supports radiation protection initiative
    The FDA has allotted grant funds to support the Center for Devices and Radiological Health's 2013 Assuring Radiation Protection program, which will aim to boost cooperation on measures to solve radiation control problems, both now and in the future. Areas of interest include the use of nonmedical ionizing radiation and medical/nonmedical nonionizing radiation, as well as the management of radiation exposure from all sources. AuntMinnie.com (free registration) (1/29) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • Report calls for U.S. to move toward preventive health model
    The nonprofit Trust for America's Health proposed shifting U.S. health care from a sick-care model to a prevention format, which economists argued may be a good thing but will not reduce health care costs. Some preventive measures do save money, though, including counseling adults about taking low-dose aspirin to prevent cardiovascular disease, which is much less expensive than the cost of treating heart disease. Reuters (1/29) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
  From SNMMI 
  • 2013 High Country Nuclear Medicine Conference: March 1-6, Vail, Colo.
    High Country continues to attract and blend experts from academia and industry with leaders in medical specialties, the regulatory agencies and health care researchers. The 2013 meeting, with anticipated attendance in excess of 130 participants, promises to open avenues and opportunities of collaboration on a variety of issues important to the nuclear medicine and molecular imaging community. Learn more. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
Any workout which does not involve a certain minimum of danger or responsibility does not improve the body -- it just wears it out."
--Norman Mailer,
American writer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information